Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 87675518 |
Registration Number | 5640578 |
Mark Drawing Code | 5000: Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form |
Domestic Representative | Bassam N. Ibrahim |
Attorney Name | Bassam N. Ibrahim |
Attorney Docket Number | 0076404-158 |
Law Office Assigned | L60 |
Employee Name | POWELL, LINDA A |
2017-11-07 | Application Filed |
2018-10-16 | Published for Opposition |
2019-01-01 | Location: PUBLICATION AND ISSUE SECTION |
2019-01-01 | Status: Live/Registered |
2019-01-01 | Trademark Registered |
2019-01-01 | Transaction Date |
Owner: | ![]() |
Address | 3-5-1, Nihonbashi Honcho, Chuo-ku Tokyo 103-8426 JP |
Legal Entity Type | Corporation |
Legal Entity State | JP |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2017-11-10 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-11-17 | 2 NWOS I:Incoming Correspondence |
TEAS VOLUNTARY AMENDMENT RECEIVED | 2017-12-11 | 3 PARI I:Incoming Correspondence |
ASSIGNED TO LIE | 2017-12-18 | 4 ALIE A:Allowance for Publication |
APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2017-12-20 | 5 AMPX O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2018-02-17 | 6 DOCK D:Assigned to Examiner |
PRIORITY ACTION WRITTEN | 2018-02-24 | 7 CPRA R:Renewal |
PRIORITY ACTION E-MAILED | 2018-02-24 | 8 GPRA F:First Action |
NOTIFICATION OF PRIORITY ACTION E-MAILED | 2018-02-24 | 9 GPRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-08-21 | 10 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2018-08-29 | 11 ALIE A:Allowance for Publication |
APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2018-08-30 | 12 AMPX O:Outgoing Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-09-08 | 13 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-09-26 | 14 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2018-10-16 | 15 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-10-16 | 16 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2019-01-01 | 17 R.PR A:Allowance for Publication |
TEAS SECTION 7 REQUEST RECEIVED | 2019-06-21 | 18 ES7R I:Incoming Correspondence |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2019-07-23 | 19 APRE A:Allowance for Publication |
POST REGISTRATION ACTION MAILED - SEC. 7 | 2019-07-26 | 20 PRAM O:Outgoing Correspondence |
AMENDMENT UNDER SECTION 7 - ISSUED | 2019-10-29 | 21 A7OK O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | 2019-11-13 | 22 EROP I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-11-13 | 23 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-11-13 | 24 ARAA I:Incoming Correspondence |
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | 2019-11-14 | 25 CORV 1: |
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2024-01-01 | 26 REM1 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.